1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A rare case report of hypertrophic cardiomyopathy induced by catecholamine-producing tumor

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rationale:

          Catecholamine-producing tumors are rare, occurring in less than 0.2% of patients with hypertension, but can have relevant cardiovascular morbidity and mortality.

          Patient concerns:

          A 37-year-old woman presented with a history of dyspnea, chest pain, palpitations, and paroxysmal hypertension. Electrocardiogram, echocardiogram, and cardiac magnetic resonance showed severe LVH with a prevalent involvement of the anterior portion of interventricular septum. Endomyocardial biopsy found severe hypertrophy with disarray of cardiomyocytes and ultrastructural evidence of contraction and necrosis of myocytes. Hormone investigations revealed high values of 24-hours urinary metanephrines. Abdominal computed tomography (CT) showed an enlarged left adrenal gland with a strong uptake of 123I—metaiodobenzylguanidine at scintigraphy scan.

          Interventions:

          Thus, the adrenal tumor was surgically removed.

          Outcomes:

          At follow-up examination, the patient's metanephrines levels were normalized and the transthoracic echocardiogram showed a reduction of LVH.

          Diagnosis and lessons:

          We report a rare case of catecholamine–induced cardiomyopathy due to an adrenal adenoma mixed with nodules enriched in epinephrine-types secreting granules.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: not found
          • Article: not found

          Cardiovascular effects of cocaine.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period.

            Use of left ventricular (LV) endomyocardial biopsy (EMB) to investigate cardiomyopathies is currently discouraged because it is considered riskier than and as contributive as right ventricular (RV) biopsy. The aim of our study is to report our experience with this option and to discuss its advantages and disadvantages.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Catecholamine-induced cardiomyopathy.

              To review the pathogenesis as well as the clinical and laboratory features of catecholamine-induced cardiomyopathy associated with pheochromocytoma and other disorders and discuss the various treatment options available. Materials used for this article were identified through MEDLINE, PubMed, and Google Scholar searches of the relevant literature from 1955 to the present. Catecholamines and their oxidation products cause a direct toxic effect on the myocardium. Catecholamines also exert a receptor-mediated effect on the myocardium. Catecholamine-mediated myocardial stunning has been implicated in the pathogenesis of stress-induced cardiomyopathy. Biopsy of the myocardium in patients with pheochromocytoma or those with stress-induced cardiomyopathy shows similar pathologic findings. The clinical features in pheochromocytoma-related cardiomyopathy include hypertension, dilated or hypertrophic cardiomyopathy, pulmonary edema due to cardiogenic and noncardiogenic factors, cardiac arrhythmias, and even cardiac arrest. Stress-related cardiomyopathy such as takotsubo cardiomyopathy occurs primarily in postmenopausal women. These patients may present with clinical features suggestive of an acute myocardial infarction or a hemodynamically compromised state. The definitive management of cardiomyopathy associated with pheochromocytoma includes medical treatment with alpha-adrenergic blockade, possibly along with angiotensin converting enzyme blockers and beta1-adrenergic receptor blockers, followed by excision of the tumor. Stress-induced cardiomyopathy is usually self-limiting; patients may require support with nonadrenergic inotropes. Recognition of catecholamine-induced cardiomyopathy, especially in patients with pheochromocytoma, before surgical treatment is important to minimize morbidity and mortality.
                Bookmark

                Author and article information

                Journal
                Medicine (Baltimore)
                Medicine (Baltimore)
                MEDI
                Medicine
                Wolters Kluwer Health
                0025-7974
                1536-5964
                December 2018
                14 December 2018
                : 97
                : 50
                : e13369
                Affiliations
                [a ]Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome
                [b ]Department of Radiological, Oncological and Anatomy-Pathological Sciences, University of Rome
                [c ]Department of Surgery “P. Valdoni”, University of Rome
                [d ]Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, University of Rome “La Sapienza” Rome, Italy.
                Author notes
                []Correspondence: Claudio Letizia, Department of Internal Medicine and Medical Specialties, Policlinico “Umberto I”, University “Sapienza”, Rome 00155, Italy (e-mail: claudio.letizia@ 123456uniroma1.it ).
                Article
                MD-D-18-05304 13369
                10.1097/MD.0000000000013369
                6319915
                30557989
                4eda1e87-1f10-4af8-8afb-00f17acd2f0b
                Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc.

                This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

                History
                : 4 August 2018
                : 31 October 2018
                Categories
                3400
                Research Article
                Clinical Case Report
                Custom metadata
                TRUE

                adrenal adenoma,catecholamine–induced cardiomyopathy,endomyocardial biopsy,pheochromocytoma

                Comments

                Comment on this article